Glen Eagle Advisors’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-100
| Closed | -$3.57K | – | 973 |
|
|
2021
Q3 | $3.57K | Hold |
100
| – | – | ﹤0.01% | 851 |
|
|
2021
Q2 | $1.98K | Hold |
100
| – | – | ﹤0.01% | 917 |
|
|
2021
Q1 | $2.33K | Buy |
+100
| New | +$2.33K | ﹤0.01% | 867 |
|
|
2019
Q4 | – | Sell |
-125
| Closed | -$1.42K | – | 908 |
|
|
2019
Q3 | $1.42K | Hold |
125
| – | – | ﹤0.01% | 737 |
|
|
2019
Q2 | $1.41K | Hold |
125
| – | – | ﹤0.01% | 718 |
|
|
2019
Q1 | $1.01K | Hold |
125
| – | – | ﹤0.01% | 694 |
|
|
2018
Q4 | $790 | Hold |
125
| – | – | ﹤0.01% | 687 |
|
|
2018
Q3 | $1.23K | Hold |
125
| – | – | ﹤0.01% | 660 |
|
|
2018
Q2 | $1.04K | Hold |
125
| – | – | ﹤0.01% | 653 |
|
|
2018
Q1 | $900 | Hold |
125
| – | – | ﹤0.01% | 646 |
|
|
2017
Q4 | $1.02K | Hold |
125
| – | – | ﹤0.01% | 604 |
|
|
2017
Q3 | $1.81K | Buy |
+125
| New | +$1.81K | ﹤0.01% | 586 |
|